로그인 회원가입
icon_bulk_order대량 주문 조회 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > ADA > Trastuzumab > TRB-Y1b

Anti-Trastuzumab Antibodies (AY1b) (recommended for PK/PD)

  • Source
    Anti-Trastuzumab Antibodies (recommended for PK/PD) (TRB-Y1b) are expressed from human 293 cells (HEK293).
  • Isotype
    IgG1 / kappa
  • Specificity
    Recognizes Trastuzumab specifically, no cross reactivity with other humanized antibodies.
  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 12 months under sterile conditions after reconstitution.
SDS-PAGE
Anti-Trastuzumab Antibodies (Cat. No. TRB-Y1b) SDS-PAGE gel

Anti-Trastuzumab Antibodies on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

Bioactivity-ELISA
Anti-Trastuzumab AntibodiesAnti-Trastuzumab Antibodies (Cat. No. TRB-Y1b) ELISA bioactivity

Immobilized Trastuzumab at 1 μg/mL (100 μL/well) can bind Anti-Trastuzumab Antibodies (Cat. No. TRB-Y1b) with a linear range of 0.4-6 ng/mL (QC tested).

Anti-Trastuzumab AntibodiesAnti-Trastuzumab Antibodies (Cat. No. TRB-Y1b) ELISA bioactivity

Immobilized Anti-Trastuzumab Antibodies (Cat. No. TRB-Y1b) at 2 μg/mL, add increasing concentrations of Trastuzumab in the 10% human serum and then add Biotinylated Anti-Trastuzumab Antibodies (recommended for PK/PD) at 2 μg/mL. Detection was performed using HRP-conjugated streptavidin with sensitivity of 48 ng/mL (QC tested).

Anti-Trastuzumab AntibodiesAnti-Trastuzumab Antibodies (Cat. No. TRB-Y1b) ELISA bioactivity

Serial dilutions of Anti-Trastuzumab Antibodies (Cat. No. TRB-Y1b) was detected by Biotinylated Human Her2, His,Avitag (Cat. No. HE2-H82E2) with a half maximal inhibitory concentration (IC50) of 4.58 μg/mL (Routinely tested).

Bioactivity-SPR
Human_FcRn_Heterodimer_Protein_SPR

Trastuzumab captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Anti-Trastuzumab Antibodies (Cat. No. TRB-Y1b) with an affinity constant of 0.729 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

  • Background
    Trastuzumab, is a monoclonal antibody used to treat breast cancer. Specifically it is used for breast cancer that is HER2 receptor positive. Trastuzumab works by binding to the HER2 receptor and slowing down cell duplication. Trastuzumab is a recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with high affinity in a cell-based assay (Kd = 5 nM) to the extracellular domain of the human epidermal growth factor receptor protein.
  • Clinical and Translational Updates
      
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

코멘트 (0)


ETD of in-stock products: 4 business days

가격(KRW) : 450,000

가격(KRW) : 3,270,000

보급 및 전시



데이터 테이블 및 파일

DMF 신청
DMF (Drug Master File)

연락처

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

상관 제품

신제품

의문 과 코맨트

This web search service is supported by Google Inc.

totop